No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

Alpha Index M

No Prescription » Products » Alpha Index M

List of Drugs:

A  B  C  D  E  F  G  H  I  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Z  #

Products M:

MACLAR Klacid

Macrobid (Nitrofurantoin)

Macrodantin (Nitrofurantoin Macrocystals)

MADOPAR Prolopa

Malirid Generic Primaquine

Marvelon Desogestrel Ethinyl Oestradiol

Maxalt (Rizatriptan)

Maximune Invirase

Maxolon Clopra

Maxolon (Metoclopramide)

MEBEX Vermox

Medrol Deltastab

MEFTAL Ponstel

Melalite Forte Cream Aclaro

Melanocyl Uvadex

MELOSET MEL

Memantine NAMENDA

M Enalapril Generic Renitec

Meprate Modus

MESACOL Asacol

Metaspray Nasonex

Metformin Generic Glucophage

Methotrexate

Methycobal Generic Mecobalamin

Metocard XL Toprol XR

METOLAR Betaloc

METOLAR H Selopres

Metpamid Reglan

METROGYL Flagyl

METROTAB 200 Metrogyl

Mevacor (Lovastatin)

M Furo Cream Elocon

Micardis Plus Generic Telmisartan Hydrochlorothiazide

Micardis Generic Telmisartan

Micardis (Telmisartan)

Microcid Indocin

MICROGEST Prometrium

Microgynon Generic Levonorgestrel Ethhinylestradiol

Microzide (Hydrochlorothiazide)

Mikostatin oral suspension Mycostatin

Minidiab Glucotrol

Minipress (Prazosin)

MINIRIN Concentraid

Minirin Melt Generic Desmopressin

Minirin Nasal Spray DDAVP

Minomycin Minocin Oral

Minomycin (Minocycline)

Minoxidil Generic Rogaine

Mirapex (Pramipexol)

Mircette (Desogestrel + Ethinyl Estradiol)

Mirtaz Remeron

MIRT Nassa

Misobit Glyset

Misoprost Cytotec

MISOPT Cosopt

MOBIC Generic Meloxicam

Mobic (Meloxicam)

Modalert

Moduretic (Amiloride and Hydrochlorothiazide)

Moduretic Generic Amiloride Hydrochlorothiazide

MODUS Amen

Mofilet Cellcept

Mofilet S Cellcept

Momecon cream Generic Mometasone Furoate

Monodoks Atridox

Monodur Generic Isosorbide 5 mononitrate

MONTAIR Singulair

Motilium (Domperidone)

Motrin (Ibuprofen)

Moxif Avelox

MT Pill Mifeprex

MTP Kit Mifeprex

Mustang Chewable Viagra

Mustang Viagra

MUVERA Mobic

Myambutol Generic Ethambutol

Myambutol (Ethambutol)

Mycelex (Clotrimazole)

Mycept S Myfortic

Myralon Generic Desogestrel

Previous  Next

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.